SS-31 (Elamipretide) is a mitochondrial-targeting research peptide sold in lyophilized powder form. It is highlighted for its antioxidant properties and protective effects against kidney injury and mitochondrial dysfunction in preclinical models. For consumers and researchers, it requires careful handling: it should be stored frozen as a dry powder for long-term stability and reconstituted in bacteriostatic water or buffers for short-term refrigerated use.
The benefits people report — backed by research.

Under the skin
For research purposes only. Not medical advice. Talk to a doctor before use.
Compare research-grade suppliers with third-party COAs and published purity data. For in-vitro and laboratory research use only — not for human consumption, diagnosis, or treatment.
Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial
The MIC-1/GDF15-GFRAL Pathway in Energy Homeostasis: Implications for Obesity, Cachexia, and Other Associated Diseases
The GDF15-GFRAL Pathway in Health and Metabolic Disease: Friend or Foe?
GDF15 research from bench to bedside
The cardiolipin-binding peptide elamipretide mitigates fragmentation of cristae networks following cardiac ischemia reperfusion in rats
First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics
The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin
Mitochondrial protein interaction landscape of SS-31
SS-31, a mitochondria-targeting peptide, ameliorates kidney disease
Elamipretide: A review of its structure, mechanism of action, and therapeutic potential
Karaa et al., Neurology (2018) MMPOWER-2 Phase 2 elamipretide in mitochondrial myopathy
Reid Thompson et al., J Am Coll Cardiol (2021) TAZPOWER elamipretide in Barth syndrome
Chavez et al., PNAS (2020) SS-31 mitochondrial protein interaction landscape
Mitochondria-targeted peptide SS-31 attenuates renal injury via an antioxidant effect in diabetic nephropathy.
The mitochondrial-targeted peptide, SS-31, improves glomerular architecture in mice of advanced age.
Key moments in SS-31’s research and regulatory timeline — sourced and dated.
The most-used peptide combinations, dosing at a glance, and what the research says — one page, one email.
No spam. Unsubscribe anytime.
Explore by goal
Related peptides
Compare